Sano Genetics

🔬 Precision neurology is changing the game. With advances like biomarker identification and AI-powered tools, we’re uncovering the root causes of neurological disorders—and tailoring care to each patient’s unique needs. 🌍 This isn’t just about breakthroughs; it’s about building a future where everyone has access to better brain health care. 📄 Read our whitepaper to explore the full potential of precision medicine in neurology. Download now: https://lnkd.in/e3D5-zEr #genetics #precisionmedicine #neurology

Time for the big one! #AASLD2024. Can't wait to head back to sunny San Diego for a scintillating liver meeting as we celebrate a massive year for both #MASH and #PBC with exciting new therapies available to patients. We also find ourselves on the watershed of true precision medicine making its way into the clinic at scale targeting genetic #MASH and #AATD. Please don't hesitate to reach out if you want to lean more about transformative approaches to Patient Finding and Engagement leveraging at-home genetic testing in our field.

Episode 161 of #TheGeneticsPodcast is live! This week, we’re joined by Michelle Teng, CEO and Co-Founder of Etcembly Ltd, and Chief Scientific Officer and Founding Executive Director at SynaptixBio Ltd. Listen in to hear her discuss: 📊 Training large language models to help identify potential future immunotherapy targets 🧬 How the Long Term Survivor Study is helping identify T-cell profiles associated with sustained cancer remission 🤝 The importance of patient parent groups in powering research into ultra-rare genetic diseases And much more. Listen by following the link below 👇 or simply search “The Genetics Podcast” on your go-to podcast platform. 🎧 https://pod.fo/e/2822d0 📽️ https://lnkd.in/dJ_WXPsP Please consider rating and reviewing us on your chosen podcast listening platform! #SanoGenetics #Genomics #Genetics #RareDisease #Immunotherapies

We're incredibly proud of our Partnerships Lead Lindsey Wahlstrom-Edwards, who in the talk below shares just how important it is to keep humanity at the heart of research. Her personal story intersects her professional one in profound and inspiring ways. Take a moment to watch; this perspective shift will stay with you. 🧡

Genetic eye diseases present urgent challenges—patients often face delayed diagnoses, limited treatment options, and uncertain futures. Our latest research clarifies these complexities, showcasing breakthroughs in gene therapy, forward-thinking approaches to rare disorders, and the powerful role of collaborative care in advancing patient outcomes. Download “Genetics in Focus: Addressing the Complexities of Genetic Eye Disease and Patient Care,” written in collaboration with Sano Genetics and Clinical Enrollment, to explore how the genetic eye disease landscape is evolving: https://hubs.ly/Q02WNyMG0 #ClinicalResearch #Opthalmology #GeneticEyeDisease #IRDs #GeneTherapy #RareDisease

3.3% of patient advocacy groups own a registry or biorepository—last week, that number just went up! The Lupus Research Alliance took a major step toward their Five-Year Strategic Plan with the launch of 𝗗𝗥𝗘𝗔𝗠—the 𝗗ata 𝗥epository, 𝗘xchange, and 𝗔nalytics 𝗣latform. But they knew they couldn’t do it alone. 💪  ↳ Sano Genetics stepped in to help boost patient engagement and keep patient excited about their research contributions and having access to their data ↳ Lifebit provided the genomics and health data software, ensuring DREAM is a secure, data-rich hub for research. Platforms like DREAM empower patients with access to their own data and ways to participate in research, while giving researchers deeper insights for recruitment and patient data analysis. 🔍 Quick shoutout to Sophia Zilber 🌺, one of my earliest connections in patient advocacy—she launched a course on patient registries last year! It's a must have resource if you're thinking or planning to launch a new patient registry! https://lnkd.in/ePYvhP2W 𝗜𝘀 𝟯.𝟯% 𝗵𝗶𝗴𝗵𝗲𝗿 𝗼𝗿 𝗹𝗼𝘄𝗲𝗿 𝘁𝗵𝗮𝗻 𝘆𝗼𝘂 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱? Every week, Zebricks spots the launch of new registries and highlights new research advancements they've contributed to across all diseases. Curious about the 300+ patient groups with registries—or the 9,000+ without one? Our platform, Zebricks, has the answers—send me a DM to learn more! #patientregistry #patientadvocacy #observationalstudy #patientresearch

On a recent episode of The Genetics Podcast, Veera Rajagopal joined the show to share his thoughts on the most exciting genetics research of the last few months. Listen in as he and Patrick dissect research on: 🌍 The adaptive evolution of human skin pigmentation 🧠 Exploring a new tau isoform for Alzheimer’s treatment 🦠 Tomoregulin-1’s defense role against herpes simplex virus ❤️ Discovery of a noncoding Mendelian mutation linked to cardiac arrhythmias 🧬 Whole genome versus whole exome sequencing A quick recap and the full episode are available here: https://lnkd.in/eJ9XCQns. \#precisionmedicine \#genetics \#clinicaltrials

On a recent episode of The Genetics Podcast, Patrick Short sat down with Noam Baumatz, CEO of NOGA Therapeutics. Noam shared the deeply personal story behind his company, and their mission to make gene therapy more accessible and effective for rare disease patients. 🧬 🔗 Read a quick recap or listen in full here: https://lnkd.in/eQxAzMg3 #Genetics #PrecisionMedicine #GeneTherapy

Thanks to everyone who attended The Genetics Podcast meetup last night at the American Society of Human Genetics Annual Meeting! 🤩 It was a pleasure to mix and mingle with some of the brightest minds in our industry. We left inspired and excited for all that’s to come in the field of precision medicine. 🧬 And if your haven’t, be sure to check out The Genetics Podcast - there are 150+ episodes available at www.thegeneticspodcast.com or wherever you get your podcasts! 🎧

The Lupus Research Alliance (LRA) is pleased to announce the launch of the  Data  Repository,  Exchange and  Analytics platforM  (DREAM), a component of the Lupus Nexus.    The DREAM consists of two distinct interfaces: a secure data-sharing and collaboration platform for researchers, and a research engagement platform for those living with lupus. The DREAM is the final component of the Lupus Nexus, a unique program that aims to accelerate precision medicine in lupus and is comprised of a Registry, a Biorepository, the DREAM, and a Quality Management System.    Learn more: https://bit.ly/LRA-DREAM #Lupus #LupusResearch #PrecisionMedicine